Profile Picture
Rewards
  • All
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Hunter pleads not guilty
Ethics violation allegations
Expecting 1st child together
2 soldiers killed, dozen hurt
Settles assault lawsuit
Shoplifter sets clerk on fire?
Govt. sues Union Pacific
Two children drown in pool
US fines Stanford $2M
Bear attacks 73-year-old
Targets $9.2B valuation
14-year-old fatally shoots 3?
WA raises minimum wage
Faces dog fighting charges
Leaves with concussion
Illinois migrant crisis
Philly: Alleged shooter killed
Violated False Claims Act
Gets trailer, premiere date
Honored w/ postage stamp
DNC diversity goals
Abduction suspect found
29 soldiers killed in Niger
Five-year, $146M extension
Open to bless gay couples?
Panda diplomacy
Angels split with Nevin
OKs 2nd malaria vaccine
First-ever space debris fine
Jackpot rises to $1.2B
Customers regain upper hand
Olympics writer dies at 61
Joins Mich. Senate race
Evergrande shares soar
‘Selling personal belongings'
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
116,000 results
Hosted on MSN1mon
UPDATE 1-EU approves Pfizer's RSV vaccine to protect infants and older adults
Aug 24 (Reuters) - The European Commission on Thursday approved U.S. drugmaker Pfizer's vaccine for respiratory syncytial virus (RSV) to protect both babies and older adults in the European Union.
Barron's1mon
EU Authorises Sale Of Vaccine Against RSV In Infants
The EU on Friday authorised the sale of a vaccine to protect infants from respiratory syncytial virus (RSV), a disease that in worst cases can lead to pneumonia and bronchiolitis. The bloc-wide ...
Hebdo Ahram1mon
EU drug watchdog approves first RSV infant vaccine
RSV normally causes mild, cold-like symptoms, but can be serious for infants the elderly, those with weak immune systems and underlying conditions, and is a leading cause of paediatric ...
Hosted on MSN1mon
FDA approves first vaccine to protect newborns from RSV
The US Food and Drug Administration on Monday approved the first vaccine that protects newborns from respiratory syncytial virus, known as RSV. The vaccine, made by Pfizer, is given to mothers ...
1d
New tests of a recently approved RSV vaccine show potent antibody response to current and past variants
New tests of a recently approved vaccine for respiratory syncytial virus—RSV—show the shot remains effective against a range ...
Nasdaq1mon
EU approves Pfizer's RSV vaccine to protect infants and older adults
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Reuters, the news and media division of Thomson Reuters, is ...
News 12 Networks1mon
FDA approves first vaccine to protect infants from RSV
The FDA has approved the first vaccine to protect infants against RSV, a respiratory virus that can be deadly. The new shot, from Pfizer, will be given to pregnant mothers. In clinical trials, it ...
AOL.co.uk1mon
EU approves Pfizer's RSV vaccine to protect infants and older adults
(Reuters) -The European Commission on Thursday approved U.S. drugmaker Pfizer's vaccine for respiratory syncytial virus (RSV) to protect both babies and older adults in the European Union.
KCCI Des Moines1mon
FDA approves first vaccine to protect newborns from RSV
The FDA has approved the first long acting drug to protect infants and toddlers from the respiratory virus known as RSV. The antibody preventive therapy called, was approved Monday for injection ...
Yahoo Finance1mon
EU approves Pfizer's RSV vaccine to protect infants and older adults
(Reuters) -The European Commission on Thursday approved U.S. drugmaker Pfizer's vaccine for respiratory syncytial virus (RSV) to protect both babies and older adults in the European Union. The ...
AOL1mon
FDA approves first vaccine to protect newborns from RSV
Still, the vaccine, given from 32 to 36 weeks of gestational age, does not provide long-term protection. For the first three months after birth, the vaccine was 82% effective at preventing severe ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices